Dr. Reddy's Laboratories
RDY
#1704
Rank
NZ$22.26 B
Marketcap
NZ$26.70
Share price
2.62%
Change (1 day)
11.14%
Change (1 year)

EPS for Dr. Reddy's Laboratories (RDY)

EPS in 2023 (TTM): NZ$6.02

According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is NZ$0.65. In 2022 the company made an earnings per share (EPS) of NZ$4.86 an increase over its 2021 EPS that were of NZ$4.11.

EPS history for Dr. Reddy's Laboratories from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$6.0223.91%
2022NZ$4.8618.14%
2021NZ$4.1134.07%
2020NZ$3.0721.36%
2019NZ$2.53-7.1%
2018NZ$2.7264.13%
2017NZ$1.667.5%
2016NZ$1.54-61.17%
2015NZ$3.975.97%
2014NZ$3.75-5.38%
2013NZ$3.9646.78%
2012NZ$2.70-13.09%
2011NZ$3.1041.17%
2010NZ$2.20-199.25%
2009NZ-$2.21-269.81%
2008NZ$1.30-12.82%
2007NZ$1.500.54%
2006NZ$1.49301.34%
2005NZ$0.3772.26%
2004NZ$0.22-68.7%
2003NZ$0.6925.18%
2002NZ$0.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.40 1,349.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36 109.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41 425.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
NZ$5.15 694.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.13 74.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel